A Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma.
Phase of Trial: Phase III
Latest Information Update: 17 Aug 2017
At a glance
- Drugs Benralizumab (Primary)
- Indications Asthma
- Focus Registrational; Therapeutic Use
- Sponsors AstraZeneca
- 23 Oct 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 11 May 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
- 15 Feb 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.